BIFULCO, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 10.646
AS - Asia 9.166
EU - Europa 2.591
SA - Sud America 335
AF - Africa 41
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 22.796
Nazione #
US - Stati Uniti d'America 10.568
HK - Hong Kong 6.014
SG - Singapore 1.254
CN - Cina 940
UA - Ucraina 618
VN - Vietnam 518
IT - Italia 496
RU - Federazione Russa 396
DE - Germania 284
BR - Brasile 282
SE - Svezia 220
IE - Irlanda 207
TR - Turchia 179
FI - Finlandia 150
KR - Corea 111
GB - Regno Unito 62
IN - India 53
CA - Canada 39
ES - Italia 27
CZ - Repubblica Ceca 24
MX - Messico 23
PL - Polonia 22
AR - Argentina 21
NL - Olanda 21
ZA - Sudafrica 20
JP - Giappone 19
BD - Bangladesh 17
FR - Francia 14
ID - Indonesia 11
AT - Austria 9
IQ - Iraq 9
CH - Svizzera 7
EU - Europa 7
UZ - Uzbekistan 7
BE - Belgio 6
IL - Israele 6
LT - Lituania 6
PY - Paraguay 6
AU - Australia 5
CO - Colombia 5
EC - Ecuador 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
DZ - Algeria 4
NZ - Nuova Zelanda 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
BY - Bielorussia 3
CR - Costa Rica 3
HN - Honduras 3
PA - Panama 3
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
PH - Filippine 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
LC - Santa Lucia 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
NA - Namibia 1
NE - Niger 1
NO - Norvegia 1
NP - Nepal 1
PR - Porto Rico 1
PT - Portogallo 1
SA - Arabia Saudita 1
SO - Somalia 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 22.796
Città #
Hong Kong 6.013
Dallas 2.954
Ann Arbor 2.160
Chandler 899
Jacksonville 751
Princeton 590
Singapore 566
Woodbridge 540
Dong Ket 424
Wilmington 394
Houston 306
Ashburn 262
Dublin 207
Nanjing 194
Izmir 170
Beijing 166
Boardman 137
Andover 132
Pellezzano 118
Munich 116
Salerno 80
Moscow 68
Los Angeles 59
Nanchang 55
Shenyang 55
Fairfield 54
Hebei 46
Jiaxing 44
Norwalk 42
Mestre 40
Changsha 35
New York 32
São Paulo 30
Ho Chi Minh City 29
Pune 29
Tianjin 27
Naples 26
Brno 23
Hanoi 23
Warsaw 21
Santa Clara 20
Dearborn 19
Düsseldorf 19
Helsinki 19
Jinan 19
Shanghai 19
Tokyo 19
Turku 19
Amsterdam 18
San Francisco 18
Seattle 18
Brooklyn 16
Johannesburg 16
Stockholm 16
The Dalles 16
San Diego 15
Columbus 14
Washington 14
Montreal 13
Seoul 13
Boston 12
Chennai 12
London 12
Qualiano 12
Redwood City 12
West Jordan 12
Zhengzhou 12
Brasília 11
Council Bluffs 11
Rome 11
Atlanta 10
Cambridge 10
Chicago 10
Denver 10
Mexico City 10
Manchester 9
Phoenix 9
Poplar 9
Guangzhou 8
Nuremberg 8
Orem 8
Bari 7
Curitiba 7
Haiphong 7
Milan 7
Nürnberg 7
Ottawa 7
Querétaro 7
Ankara 6
Brussels 6
Hangzhou 6
Hefei 6
Lanzhou 6
Porto Alegre 6
Secaucus 6
Tashkent 6
Avellino 5
Belo Horizonte 5
Falls Church 5
Indiana 5
Totale 18.592
Nome #
1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor 2.925
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis 1.493
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells. 1.016
The endocannabinoid signaling system in cancer 864
Concomitant BRAFV600E mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma. 545
N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux 488
Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colorectal cancer cells. 479
Higher farnesyl diphosphate synthase activity in human colorectal cancer: inhibition of cellular apoptosis 326
Phytocannabinoids and cannabimimetic drugs: Recent patents in central nervous system disorders 320
The isoprenoid derivative N6-benzyladenosine (CM223) exerts antitumor effect in glioma patient-derived primary cells through the mevalonate pathway 300
Immuno-modulatory and anti-inflammatory effects of dihydrogracilin a, a terpene derived from the marine sponge Dendrilla membranosa 272
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon 257
Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation 243
Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor. 207
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells. 203
Identification of CM223 as a new ligand of farnesyl pyrophosphate synthase with improved antiglioma action 189
Structural Evidence ofN6-Isopentenyladenosine As a New Ligand of Farnesyl Pyrophosphate Synthase 187
Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma 176
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration. 166
Binding of the hemopressin peptide to the cannabinoid CB(1) receptor: structural insights. 164
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation 161
Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. 143
Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines 142
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects 142
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation 140
Dental care and dentistry practice in the Medieval Medical School of Salerno 140
Cannabidiol: State of the art and new challenges for therapeutic applications 138
Calcium/calmodulin-dependent protein kinase II (CaMKII) phosphorylates Raf-1 at serine 338 and mediates Ras-stimulated Raf-1 activation. 135
Applicazione degli inibitori della prenilazione nelle patologie proliferative della tiroide: la lovastatina induce apoptosi in cellule tiroidee umane. 135
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells 134
Brain cancer risk: the weight of obesity 133
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 133
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth. 130
What we know and do not know about the cannabinoid receptor 2 (CB2) 128
Apoptosis induced by denied adhesion to extracellular matrix (anoikis) in thyroid epithelial cells is p53 dependent but fails to correlate with modulation of p53 expression. 127
Association between Cannabinoid type-1 receptor polymorphism and body mass index in a Southern Italian population. Int J Obesity 126
Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state. 126
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer 126
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake. 121
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives. 119
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells. 117
Leucine enhances aerosol performance of Naringin dry powder and its activity on cystic fibrosis airway epithelial cells 117
The cannabinoid CB1 receptor antagonist Rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating phosphatidylinositol-3-kinase activity. 116
N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A 115
Antiangiogenic activity of the endocannabinoid anandamide. Correlation to its tumour-suppressor efficacy 113
“Adiponcosis”: A New Term to Name the Obesity and Cancer Link 113
Thyroid adiponcosis: more than an hypothesis 112
17-beta estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing Erk-1 and -2 MAP kinases activation 107
Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells. 106
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity. 106
A new role of anandamide in human sperm: focus on metabolism 106
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism. 105
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis 103
Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation 103
Dietary and hypothyroid hypercholesterolemia induces hepatic apolipoprotein E expression in the rat: direct role of cholesterol. 102
Molecular mechanisms responsible for neuroinflammation and neurological impairments in mevalonate kinase deficiency 101
The right to care and the expectations of society?controversial stem cell therapy in Italy 101
Statins and cancer in gastroenterology: new insight? 99
Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug 99
Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression 98
Breast adiponcosis: a call for further research 98
v-K-ras leads to preferential farnesylation of p21ras in FRTL-5 cells: multiple interference with the isoprenoid pathway 97
Updates on Adiponcosis: More new incoming evidence strengthening the obesity-cancer link 97
The basis of the modern medical hygiene in the medieval Medical School of Salerno 95
A focus on Trotula de' Ruggiero: A pioneer in women's and children's health in history of medicine 95
Statins and cancer-related mortality: an open question. 94
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis. 93
Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction. 93
Cannabinoid receptor 1 antagonism in hepatocellular carcinoma: Killing two birds with one stone 93
Cannabinoids and cancer: pros and cons of an antitumour strategy. 92
Statins in neurological disorders: an overview and update 90
Statin reduces orbitopathy risk in patients with Graves’ disease by modulating apoptosis and autophagy activities 90
Verminoside- and verbascoside-induced genotoxicity on human lymphocytes: involvement of PARP-1 and p53 proteins. 89
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. 89
The HMG-CoA reductase inhibitor lovastatin induces apoptosis in proliferating human thyroid cells. 89
Comment on “the negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.” 89
The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells 88
N(6)-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1 87
2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin 87
Modern History of Medical Cannabis: From Widespread Use to Prohibitionism and Back 86
Mediterranean diet: The missing link between gut microbiota and inflammatory diseases 85
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents 84
Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients 84
Trotula e le piante medicinali mediterranee: dal Medioevo alla cosmetologia moderna 83
End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion. 83
The medieval skincare routine according to the formulations of Madgistra Trotula and the Medical School of Salerno and its reflection on cosmetology of the third millennium 82
Rimonabant-induced apoptosis in leukemia cell lines: Activation of caspase-dependent and -independent pathways 81
Antibiotics exposure in obesity: an update of a complex relationship 81
Cannabinoid receptor CB1 antagonists state of the art and challenges 80
Novel prospects of statins as therapeutic agents in cancer 80
Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines 80
The anandamide analogue, Met-F-AEA, controls human breast cancer cell migration via the RhoA/Rho kinase signaling pathway. 78
The complex interplay among hepatocytes and immune cells at the crossroad between inflammation and cholesterol metabolism in hyperglycemia 78
Comment on 'When in Rome, reform'. 76
The new task for medical scientists 76
Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors. 75
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells. 75
Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice. 75
Fatty acid synthase hyperactivation in human colorectal cancer: relationship with tumor side and sex. 75
The endocannabinoid system and its therapeutic exploitation. 74
Totale 19.054
Categoria #
all - tutte 66.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.464


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.093 0 0 0 0 146 58 142 6 121 1 147 472
2021/20221.029 6 3 2 14 53 14 3 47 141 145 147 454
2022/20231.870 173 145 14 278 271 382 10 184 262 13 82 56
2023/2024670 68 105 42 30 48 114 14 28 8 35 49 129
2024/20251.870 116 27 106 99 79 184 310 170 269 70 204 236
2025/202610.641 2.521 3.062 3.814 446 798 0 0 0 0 0 0 0
Totale 23.102